Compounds for the treatment of covid-19 KU LeuvenPieter LeyssenThe present invention relates to compounds that are able to inhibt functional proteins of COVID-19 virus, SARS-Cov-2.
Compounds for the treatment of covid-19 KU LeuvenPieter LeyssenThe present invention relates to compounds that are able to inhibt 3CL protease of COVID-19 virus, SARS-Cov-2
Compounds for the treatment of covid-19 KU LeuvenThe present invention relates to compounds for the treatment of a SARS-Cov-2 infection in a subject.
Compounds for the treatment of covid-19 KU LeuvenThe present invention relates to compounds for the treatment of a SARS-Cov-2 infection in a subject.